Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001179110-20-009204
Filing Date
2020-08-20
Accepted
2020-08-20 19:03:17
Documents
2
Period of Report
2020-08-10

Document Format Files

Seq Description Document Type Size
1 FORM 3 - edgar.html 3  
1 FORM 3 - edgar.xml 3 1688
2 ex24santos.txt EX-24 3355
  Complete submission text file 0001179110-20-009204.txt   6387
Mailing Address 1180 VETERANS BOULEVARD SOUTH SAN FRANCISCO CA 94080
Business Address 1180 VETERANS BOULEVARD SOUTH SAN FRANCISCO CA 94080
RIGEL PHARMACEUTICALS INC (Issuer) CIK: 0001034842 (see all company filings)

EIN.: 943248524 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address RIGEL PHARMACEUTICALS, INC. 1180 VETERANS BLVD. SOUTH SAN FRANCISCO CA 94080
Business Address
Santos David A (Reporting) CIK: 0001820066 (see all company filings)

Type: 3 | Act: 34 | File No.: 000-29889 | Film No.: 201121164